In DSS and TNBS induced colitis models, orally administered KPV has consistently reduced disease activity scores, lowered inflammatory cytokine levels, decreased mucosal damage, and helped restore gut barrier function
Compatible Formulation Types Aqueous or light gel serums O/W emulsions (creams and lotions) Eye contour treatments Sheet mask essences Non-rinsed scalp sprays and leave-on tonics Facial cream formulations Compatibility with Other Actives & System Design Synergistic Combinations GHK-Cu works effectively alongside these active ingredients: Low-strength retinoids : Complementary anti-aging action Niacinamide : Barrier support and brightening Panthenol : Soothing and hydrating Ceramides : Barrier restoration Hyaluronic acid : Hydration and plumping Mild alpha hydroxy acids in night products : Gentle exfoliation Vitamin E and ferulic acid : Antioxidant properties enhancement Combinations Requiring Caution High-percentage glycolic or lactic acid : Can destabilize peptides Low-pH ascorbic acid (direct vitamin C) : May affect copper state Excessive chelators : Compete for copper binding Recommendation : Sequence potentially incompatible actives in separate products within a regimen rather than combining in single formulations
We want to make sure you get the best value while reaching your skin and body goals
With consistent daily use, many users begin to notice visible changeslike reduced shedding, improved scalp condition, and signs of regrowtharound the 120 to 150 day mark
Follicle miniaturisation The gradual shrinking of hair follicles that occurs in pattern baldness (androgenetic alopecia)
Chemotoxicity and Cellular Protection Research Some preclinical studies suggest FOXO4-DRI may help reduce tissue damage associated with certain chemotherapy compounds, including doxorubicin
